Thor Medical ASA Total Liabilities
Thor Medical ASA total liabilities. Based on the latest financial reports, Thor Medical ASA (TRMED) has total liabilities worth Nkr314.10 Million NOK (≈ $33.05 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Thor Medical ASA liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Thor Medical ASA (2019–2025)
Total liabilities of Thor Medical ASA from 2019 to 2025. This chart illustrates how Thor Medical ASA's total liabilities have evolved over time, based on quarterly financial data. Check TRMED cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Thor Medical ASA Competitors by Total Liabilities
The table below lists competitors of Thor Medical ASA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Evgo Inc
NASDAQ:EVGO
|
USA | $657.31 Million |
|
1RT Acquisition Corp.
NASDAQ:ONCH
|
USA | $8.32 Million |
|
Waterco Ltd
AU:WAT
|
Australia | AU$134.40 Million |
|
Falcon Oil & Gas Ltd
F:FAC
|
Germany | €18.06 Million |
|
Onward Medical N.V.
BR:ONWD
|
Belgium | €29.24 Million |
|
Astral Resources NL
AU:AAR
|
Australia | AU$4.92 Million |
|
Tukas Gida Sanayi ve Ticaret AS
IS:TUKAS
|
Turkey | TL9.65 Billion |
|
Brightcom Group Limited
NSE:BCG
|
India | Rs-105.71 Billion |
Liability Composition Analysis (2019–2025)
This chart breaks down Thor Medical ASA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Thor Medical ASA.
Liquidity & Leverage Metrics
Thor Medical ASA Total Liabilities Ratios Explained
Thor Medical ASA total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.89 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.77 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Thor Medical ASA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Thor Medical ASA (2019–2025)
The table below shows the annual total liabilities of Thor Medical ASA from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Nkr252.64 Million ≈ $26.58 Million |
+226.83% |
| 2024-12-31 | Nkr77.30 Million ≈ $8.13 Million |
+31.22% |
| 2023-12-31 | Nkr58.91 Million ≈ $6.20 Million |
+28.62% |
| 2022-12-31 | Nkr45.80 Million ≈ $4.82 Million |
-70.67% |
| 2021-12-31 | Nkr156.16 Million ≈ $16.43 Million |
+14.87% |
| 2020-12-31 | Nkr135.94 Million ≈ $14.31 Million |
+2874.01% |
| 2019-12-31 | Nkr4.57 Million ≈ $481.00K |
-- |
About Thor Medical ASA
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway.